These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immunotherapy of human tumors. Sinkovics JG Pathobiol Annu; 1978; 8():241-84. PubMed ID: 364375 [No Abstract] [Full Text] [Related]
8. Platelet transfusions in 75 patients undergoing autologous bone marrow transplantation. Lund BV; Madsen M Transplant Proc; 1994 Jun; 26(3):1825. PubMed ID: 8030156 [No Abstract] [Full Text] [Related]
9. Application of monoclonal antibodies to tumor diagnosis and therapy. Rosen ST; Winter JN; Epstein AL Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022 [TBL] [Abstract][Full Text] [Related]
10. [Bone marrow transplantation in man. III: transplantation of autologous bone marrow]. Izzi T; Lucarelli G Recenti Prog Med; 1983 Apr; 74(4):479-91. PubMed ID: 6348902 [No Abstract] [Full Text] [Related]
11. The European Group for Blood and Marrow Transplantation (EBMT): a report from the president and the chairmen of the working parties. Gratwohl A; Gorin C; Apperley J; Goldstone A; Rosti G; Bacigalupo A; Gluckman E; Fischer A; Ljungman P; Kolb HJ; Niethammer D Bone Marrow Transplant; 1996 Oct; 18(4):677-91. PubMed ID: 8899181 [No Abstract] [Full Text] [Related]
12. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors]. Nachbaur D; Schwaighofer H; Thaler J; Weyrer W; Fink M; Nussbaumer W; Fritsch E; Niederwieser D Wien Klin Wochenschr; 1994; 106(7):201-7. PubMed ID: 8197754 [TBL] [Abstract][Full Text] [Related]
13. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation. Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186 [TBL] [Abstract][Full Text] [Related]
14. Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD. Wawer A; Laws HJ; Dilloo D; Göbel U; Burdach S Klin Padiatr; 2004; 216(3):169-75. PubMed ID: 15175962 [TBL] [Abstract][Full Text] [Related]
15. Rapid and safe automated processing of bone marrow grafts without using density gradient cryopreservation and transplantation. Deméocq F; Kanold J; Bezou MJ; Travade P; Chassagne J; Berger M Prog Clin Biol Res; 1994; 389():675-84. PubMed ID: 7700935 [No Abstract] [Full Text] [Related]
16. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody. Alonso K; Medenica R; Morehead G Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892 [No Abstract] [Full Text] [Related]
17. Biologicals for cancer treatment: monoclonal antibodies. Levy R Hosp Pract (Off Ed); 1985 Nov; 20(11):67-74, 77, 80-4 passim. PubMed ID: 3932392 [No Abstract] [Full Text] [Related]
18. Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia. Griskevicius L; Stulpinas R; Vengalyte I; Saulyte-Trakymiene S; Mickys U; Pranys D; Kurtinaitis J; Jurgutis M Leuk Res; 2009 Apr; 33(4):587-8. PubMed ID: 18762337 [No Abstract] [Full Text] [Related]
19. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow and peripheral blood stem cell transplantation for malignancy. Johnson PW; Simnett SJ; Sweetenham JW; Morgan GJ; Stewart LA Health Technol Assess; 1998; 2(8):1-187. PubMed ID: 9728295 [No Abstract] [Full Text] [Related] [Next] [New Search]